Evenity Will Be a New Injectable for Postmenopausal Osteoporosis

You'll hear about Evenity (ee-VEN-ih-tee, romosozumab), a new injectable med for postmenopausal women with osteoporosis.

Evenity increases bone growth AND decreases bone breakdown. Other osteoporosis meds (alendronate, Forteo, etc) only do one or the other.

Expect Evenity to be saved for high-risk women...such as those with a prior fracture on a bisphosphonate (alendronate, etc) or with multiple back fractures.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals